| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| t-226296 | voltage-gated potassium channel kv1.5 | NA | Successful target | TTD , DGIDB | Atrial Fibrillation[MeSHID:D001281] Obesity[MeSHID:D009765] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.68 | preclinical | unknown |
| t-226296 | melanin-concentrating hormone receptor 1 | NA | Clinical trial target | TTD , DGIDB | Atrial Fibrillation[MeSHID:D001281] Obesity[MeSHID:D009765] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
12.73 | preclinical | antagonist |
| t-226296 | melanin-concentrating hormone receptor 1 | NA | Clinical trial target | TTD , DGIDB | Atrial Fibrillation[MeSHID:D001281] Obesity[MeSHID:D009765] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
12.73 | preclinical | unknown |
| click here to return to the previous page | ||||||||